​

Merck (MRK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MRK Stock Forecast

Merck (MRK) stock forecast, based on 38 Wall Street analysts, predicts a 12-month average price target of $160.47, with a high of $180.00 and a low of $105.00. This represents a 9.38% increase from the last price of $146.71.

$100 $116 $132 $148 $164 $180 High: $180 Avg: $160.47 Low: $105 Last Closed Price: $146.71

MRK Stock Rating

Merck stock's rating consensus is Buy, based on 38 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 26 Buy (68.42%), 11 Hold (28.95%), 1 Sell (2.63%), and 0 Strong Sell (0.00%).

Buy
Total 38 1 11 26 Strong Sell Sell Hold Buy Strong Buy

MRK Price Target Upside V Benchmarks

TypeNameUpside
StockMerck9.38%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks2.95%

Price Target Trends

1M3M12M
# Anlaysts82451
Avg Price Target$160.13$162.21$145.80
Last Closing Price$146.71$146.71$146.71
Upside/Downside9.15%10.57%-0.62%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 265149--28
Oct, 265148--27
Sep, 265158--28
Aug, 264158-128
Jul, 264159-129
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 02, 2026Carter GouldCantor Fitzgerald$155.00$147.944.77%5.65%
Oct 30, 2026Vamil DivanGuggenheim$171.00$146.3316.86%16.56%
Oct 30, 2026KeyBanc$165.00$146.3312.76%12.47%
Oct 26, 2026Barclays$180.00$145.2723.91%22.69%
Oct 22, 2026Wells Fargo$165.00$147.2412.06%12.47%
Oct 19, 2026Goldman Sachs$155.00$146.275.97%5.65%
Oct 12, 2026Trung HuynhRBC Capital$145.00$145.60-0.41%-1.17%
Oct 08, 2026Carter GouldCantor Fitzgerald$145.00$142.791.55%-1.17%
Sep 29, 2026Scotiabank$180.00$147.1522.32%22.69%
Sep 11, 2026Luisa HectorBerenberg Bank$137.00$144.71-5.33%-6.62%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 30, 2026GuggenheimBuyBuyhold
Oct 30, 2026Bank of America SecuritiesBuyBuyhold
Oct 27, 2026Cantor FitzgeraldNeutralNeutralhold
Oct 26, 2026BarclaysOverweightOverweighthold
Oct 12, 2026CitigroupNeutralNeutralhold
Oct 12, 2026RBC CapitalSector PerformSector Performhold
Oct 08, 2026GuggenheimBuyBuyhold
Sep 29, 2026ScotiabankOutperformOutperformhold
Sep 29, 2026BernsteinMarket PerformMarket Performhold
Sep 22, 2026Cantor FitzgeraldNeutralNeutralhold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.16$5.73$0.14$6.76$7.28---
Avg Forecast$5.79$7.39$1.38$7.76$9.23$10.03$10.74$10.74
High Forecast$5.96$7.71$1.46$7.87$10.03$11.36$12.56$11.28
Low Forecast$5.63$7.17$1.33$7.64$7.89$8.36$8.52$10.51
Surprise %-10.88%-22.46%-89.86%-12.89%-21.13%---

Revenue Forecast

$45B $52B $59B $66B $73B $80B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$48.70B$59.28B$60.12B$64.17B$65.01B---
Avg Forecast$48.52B$59.12B$59.97B$63.99B$67.11B$70.95B$74.43B$75.50B
High Forecast$49.59B$61.06B$60.30B$64.28B$68.80B$71.14B$74.90B$78.42B
Low Forecast$47.46B$57.78B$59.81B$63.75B$66.44B$70.77B$73.97B$74.24B
Surprise %0.38%0.27%0.24%0.28%-3.12%---

Net Income Forecast

$0 $7B $14B $21B $28B $35B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$13.05B$14.52B$365.00M$17.12B$18.25B---
Avg Forecast$12.27B$14.91B$365.00M$19.76B$21.95B$24.45B$26.84B$27.37B
High Forecast$14.72B$17.89B$438.00M$20.06B$25.55B$28.92B$32.00B$28.74B
Low Forecast$9.81B$11.93B$292.00M$19.46B$20.09B$21.30B$21.71B$26.77B
Surprise %6.36%-2.62%--13.37%-16.86%---

MRK Forecast FAQ

Is Merck stock a buy?

Merck stock has a consensus rating of Buy, based on 38 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 26 Buy, 11 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Merck is a favorable investment for most analysts.

What is Merck's price target?

Merck's price target, set by 38 Wall Street analysts, averages $160.47 over the next 12 months. The price target range spans from $105 at the low end to $180 at the high end, suggesting a potential 9.38% change from the previous closing price of $146.71.

How does Merck stock forecast compare to its benchmarks?

Merck's stock forecast shows a 9.38% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the drug manufacturers - general stocks industry (2.95%).

What is the breakdown of analyst ratings for Merck over the past three months?

  • November 2026: 17.86% Strong Buy, 50.00% Buy, 32.14% Hold, 0% Sell, 0% Strong Sell.
  • October 2026: 18.52% Strong Buy, 51.85% Buy, 29.63% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 17.86% Strong Buy, 53.57% Buy, 28.57% Hold, 0% Sell, 0% Strong Sell.

What is Merck’s EPS forecast?

Merck's average annual EPS forecast for its fiscal year ending in December 2026 is $10.03, marking a 37.77% increase from the reported $7.28 in 2025. Estimates for the following years are $10.74 in 2027, and $10.74 in 2028.

What is Merck’s revenue forecast?

Merck's average annual revenue forecast for its fiscal year ending in December 2026 is $70.95B, reflecting a 9.14% increase from the reported $65.01B in 2025. The forecast for 2027 is $74.43B, and $75.5B for 2028.

What is Merck’s net income forecast?

Merck's net income forecast for the fiscal year ending in December 2026 stands at $24.45B, representing an 33.93% increase from the reported $18.25B in 2025. Projections indicate $26.84B in 2027, and $27.37B in 2028.